In The News View All

  • Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mell...
    ABSTRACTBackgroundP2Y12 inhibitor monotherapy with ticagrelor after a brief period of dual antiplatelet therapy can reduce bleeding without increasing ischemic harm after percutaneous coronary intervention (PCI). The impact of this approach among patients with diabetes mellitus (DM) remains unknown.ObjectivesTo examine the ...
    Published on 2020-03-30
  • Protecting the future of medicine during the COVID-19 pandemic
    AHA COVID-19 newsroom DALLAS, April 6, 2020 — The American Heart Association believes that prematurely allowing medical trainees to provide patient care during the COVID-19 pandemic could put the next generation of medical professionals at serious ...
    Published on 2020-04-06

Authors